The results revealed a significant reduction in CD31-marked microvessels within the pancreatic cancer sites of mice treated with CAR-M (Fig. 6A), indicating a decrease in vascular density and angiogenic capability following treatment with c-Met CAR macrophages. Here, MET is linked to pancreatic neoplasm.